
Cabot (CBT) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
936.0M
Gross Profit
241.0M
25.75%
Operating Income
162.0M
17.31%
Net Income
105.0M
11.22%
EPS (Diluted)
$1.69
Balance Sheet Metrics
Total Assets
3.8B
Total Liabilities
2.2B
Shareholders Equity
1.6B
Debt to Equity
1.38
Cash Flow Metrics
Operating Cash Flow
78.0M
Free Cash Flow
-26.0M
Revenue & Profitability Trend
Cabot Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.0B | 3.9B | 4.3B | 3.4B | 2.6B |
Cost of Goods Sold | 3.0B | 3.1B | 3.4B | 2.6B | 2.1B |
Gross Profit | 960.0M | 839.0M | 885.0M | 799.0M | 500.0M |
Gross Margin % | 24.0% | 21.3% | 20.5% | 23.4% | 19.1% |
Operating Expenses | |||||
Research & Development | 63.0M | 57.0M | 55.0M | 56.0M | 57.0M |
Selling, General & Administrative | 283.0M | 253.0M | 258.0M | 289.0M | 292.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 346.0M | 310.0M | 313.0M | 345.0M | 349.0M |
Operating Income | 614.0M | 529.0M | 572.0M | 454.0M | 151.0M |
Operating Margin % | 15.4% | 13.5% | 13.2% | 13.3% | 5.8% |
Non-Operating Items | |||||
Interest Income | 32.0M | 31.0M | 11.0M | 8.0M | 8.0M |
Interest Expense | 81.0M | 90.0M | 56.0M | 49.0M | 53.0M |
Other Non-Operating Income | -36.0M | -19.0M | -192.0M | -7.0M | -138.0M |
Pre-tax Income | 529.0M | 451.0M | 335.0M | 406.0M | -33.0M |
Income Tax | 111.0M | -28.0M | 102.0M | 123.0M | 191.0M |
Effective Tax Rate % | 21.0% | -6.2% | 30.4% | 30.3% | 0.0% |
Net Income | 424.0M | 484.0M | 243.0M | 286.0M | -221.0M |
Net Margin % | 10.6% | 12.3% | 5.6% | 8.4% | -8.5% |
Key Metrics | |||||
EBITDA | 761.0M | 688.0M | 720.0M | 615.0M | 307.0M |
EPS (Basic) | $7.00 | $8.06 | $3.65 | $4.41 | $-4.21 |
EPS (Diluted) | $6.72 | $7.73 | $3.62 | $4.34 | $-4.21 |
Basic Shares Outstanding | 54297251 | 55243804 | 56500000 | 56726818 | 56466638 |
Diluted Shares Outstanding | 54297251 | 55243804 | 56500000 | 56726818 | 56466638 |
Income Statement Trend
Cabot Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 223.0M | 238.0M | 206.0M | 168.0M | 151.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 733.0M | 695.0M | 836.0M | 645.0M | 418.0M |
Inventory | 552.0M | 585.0M | 664.0M | 523.0M | 359.0M |
Other Current Assets | 97.0M | 108.0M | 114.0M | 89.0M | 50.0M |
Total Current Assets | 1.6B | 1.6B | 1.8B | 1.4B | 978.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 235.0M | 228.0M | 229.0M | 241.0M | 244.0M |
Goodwill | 319.0M | 328.0M | 321.0M | 380.0M | 371.0M |
Intangible Assets | 53.0M | 60.0M | 63.0M | 100.0M | 103.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 388.0M | 352.0M | 223.0M | 225.0M | 213.0M |
Total Non-Current Assets | 2.1B | 2.0B | 1.7B | 1.9B | 1.8B |
Total Assets | 3.7B | 3.6B | 3.5B | 3.3B | 2.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 495.0M | 438.0M | 533.0M | 480.0M | 316.0M |
Short-term Debt | 53.0M | 182.0M | 354.0M | 445.0M | 21.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 772.0M | 822.0M | 1.1B | 1.1B | 529.0M |
Non-Current Liabilities | |||||
Long-term Debt | 1.2B | 1.2B | 1.2B | 801.0M | 1.2B |
Deferred Tax Liabilities | 42.0M | 50.0M | 65.0M | 73.0M | 58.0M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 1.4B | 1.4B | 1.4B | 1.1B | 1.4B |
Total Liabilities | 2.1B | 2.2B | 2.5B | 2.2B | 2.0B |
Equity | |||||
Common Stock | 54.0M | 55.0M | 56.0M | 57.0M | 57.0M |
Retained Earnings | 1.7B | 1.6B | 1.3B | 1.2B | 989.0M |
Treasury Stock | 3.0M | 3.0M | 4.0M | 4.0M | 4.0M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.6B | 1.4B | 1.0B | 1.1B | 814.0M |
Key Metrics | |||||
Total Debt | 1.2B | 1.4B | 1.5B | 1.2B | 1.2B |
Working Capital | 833.0M | 804.0M | 715.0M | 278.0M | 449.0M |
Balance Sheet Composition
Cabot Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 424.0M | 484.0M | 243.0M | 286.0M | -221.0M |
Depreciation & Amortization | 151.0M | 144.0M | 146.0M | 160.0M | 158.0M |
Stock-Based Compensation | 25.0M | 20.0M | 23.0M | 21.0M | 9.0M |
Working Capital Changes | 65.0M | 103.0M | -438.0M | -221.0M | 163.0M |
Operating Cash Flow | 691.0M | 599.0M | -70.0M | 276.0M | 247.0M |
Investing Activities | |||||
Capital Expenditures | -241.0M | -237.0M | -193.0M | -195.0M | -200.0M |
Acquisitions | 0 | 6.0M | 70.0M | 0 | -92.0M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | 0 |
Investing Cash Flow | -235.0M | -214.0M | -118.0M | -186.0M | -288.0M |
Financing Activities | |||||
Share Repurchases | -172.0M | -98.0M | -53.0M | -3.0M | -44.0M |
Dividends Paid | -93.0M | -88.0M | -84.0M | -80.0M | -80.0M |
Debt Issuance | 15.0M | 84.0M | 394.0M | 200.0M | 444.0M |
Debt Repayment | -158.0M | -287.0M | -372.0M | -222.0M | -410.0M |
Financing Cash Flow | -543.0M | -600.0M | 145.0M | -60.0M | -132.0M |
Free Cash Flow | 451.0M | 351.0M | -111.0M | 62.0M | 177.0M |
Net Change in Cash | -87.0M | -215.0M | -43.0M | 30.0M | -173.0M |
Cash Flow Trend
Cabot Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.35
Forward P/E
9.33
Price to Book
2.73
Price to Sales
1.10
PEG Ratio
-1.74
Profitability Ratios
Profit Margin
11.14%
Operating Margin
18.09%
Return on Equity
29.44%
Return on Assets
10.92%
Financial Health
Current Ratio
2.13
Debt to Equity
72.97
Beta
0.86
Per Share Data
EPS (TTM)
$7.64
Book Value per Share
$28.96
Revenue per Share
$70.58
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cbt | 4.2B | 10.35 | 2.73 | 29.44% | 11.14% | 72.97 |
Linde plc | 222.6B | 34.37 | 5.86 | 17.01% | 20.02% | 60.56 |
Sherwin-Williams | 91.5B | 36.39 | 20.70 | 62.43% | 11.03% | 308.57 |
Albemarle | 9.9B | 33.52 | 1.26 | -9.99% | -22.39% | 35.76 |
Eastman Chemical | 7.6B | 9.28 | 1.30 | 14.39% | 8.96% | 90.60 |
NewMarket | 7.4B | 15.62 | 4.60 | 33.74% | 17.28% | 56.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.